About YOURCHOICE THERAPEUTICS, INC.
YourChoice Therapeutics is a biotechnology company developing YCT-529, an investigational, non-hormonal oral male contraceptive currently in Phase 2 clinical trials. The drug targets the retinoic acid receptor-alpha (RAR-alpha) to block sperm production in a reversible manner.
Is this your company?
Claim YOURCHOICE THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim YOURCHOICE THERAPEUTICS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.